U
Roche Holding AG
OTC
Recommendation
--
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
$196.69B
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
$15.88
My Lists My Alerts
Report
Rating
Reward
U
Unrated
Risk
U
Unrated
Rating Factors
Growth Index
Unrated
Efficiency Index
Unrated
Solvency Index
Unrated
Total Return Index
Unrated
Volatility Index
Unrated
Dividend Index
Unrated
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$67.30B
EBITDA (TTM)
$23.23B
EBIT (TTM)
$19.74B
Net Income (TTM)
$12.76B
Balance Sheet
Total Assets (Q)
$107.44B
Total Debt (Q)
$36.64B
Total Liabilities (Q)
$67.93B
Book Value Per Share (Q)
$43.67
Cash Flow
Cash from Operations (TTM)
$17.93B
Cash from Investing (TTM)
-$12.02B
Cash from Financing (TTM)
-$4.51B
Net Change in Cash (TTM)
$478.84M
Filings
Filing Date
Thursday, February 1, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of Jul 22 and 26 (est)
Price History
Loading...
Beta
--
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
-- - --
52-week High
-- - --
Valuation
Market Cap
$196.69B - Large Cap
Enterprise Value
$223.41B
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
804.00M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.roche.com
Phone Number
41 61 688 11 11
Address
Grenzacherstrasse 124
Basel, 4058
Country
Switzerland
Year Founded
1896
Business Description
Sector
--
Industry
--
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical... more
Weiss Ratings